Evolution of Corporate Governance in Emerging Economies – Indian Experience

2020 ◽  
Author(s):  
Asish K. Bhattacharyya
Author(s):  
Jing Li ◽  
Daniel Shapiro

This chapter reviews the literature on foreign direct investments among emerging economies (E-E FDI), focusing on the motivations behind E-E FDI, country-specific advantages and firm-specific advantages associated with emerging-economy multinational enterprises (EMNEs), and spillover effects of E-E FDI on host-country economic and institutional development. We identify the following topics as posing important questions for future research: EMNEs’ ability to leverage home-government resources and diplomatic connections to promote investment in other emerging economies; nonmarket strategies of EMNEs in emerging economies; ownership and corporate governance affecting investment strategy and performance of EMNEs; E-E FDI contributions to sustainable development in host countries. Future studies should also consider potential heterogeneity among EMNEs by integrating insights from institutional theory, network theory, political science, corporate governance, corporate social responsibility, and sustainable-development research.


2020 ◽  
Vol 16 (1) ◽  
Author(s):  
Tatiana Dănescu ◽  
Maria-Alexandra Popa

Abstract Background Corporate social responsibility (CSR) is studied from many perspectives and has gained unprecedented importance in recent years, especially in emerging economies. Pharmaceutical companies play a very important role in a population’s well-being and health through the CSR and corporate governance practices that they apply. Methods We used an exploratory approach to measure compliance with the Corporate Governance Code of pharmaceutical companies listed on the Romanian capital market and with practices declared through CSR. Results The results show that pharmaceutical companies are involved in actions that consider the well-being of society by offering financial support and managing various sustainable projects, targeting social and economic issues, leading public health awareness campaigns, and investing in health projects. Conclusion This study highlights the increasingly important role played by corporate governance and corporate social responsibility in pharmaceutical companies in improving public health in countries with emerging economies.


2018 ◽  
Vol 50 (34-35) ◽  
pp. 3812-3832 ◽  
Author(s):  
Alin Marius Andrieș ◽  
Bogdan Căpraru ◽  
Simona Nistor

2019 ◽  
Vol 54 (4) ◽  
pp. 234-243 ◽  
Author(s):  
Sumon Bhaumik ◽  
Nigel Driffield ◽  
Ajai Gaur ◽  
Tomasz Mickiewicz ◽  
Paul Vaaler

Sign in / Sign up

Export Citation Format

Share Document